Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

Electro-mechanical (dys-)function in long QT syndrome type 1.

Ziupa D, Menza M, Koppermann S, Moss R, Beck J, Franke G, Perez Feliz S, Brunner M, Mayer S, Bugger H, Koren G, Zehender M, Jung BA, Seemann G, Foell D, Bode C, Odening KE.

Int J Cardiol. 2018 Jul 9. pii: S0167-5273(18)31662-0. doi: 10.1016/j.ijcard.2018.07.050. [Epub ahead of print]

PMID:
30017522
2.

Calcium and zinc tune autoinflammatory toll-like receptor 4 signaling by S100A12.

Kessel C, Fuehner S, Zell J, Zimmermann B, Drewianka S, Brockmeyer S, Holzinger D, Hinze C, Wittkowski H, Foell D.

J Allergy Clin Immunol. 2018 Jul 3. pii: S0091-6749(18)30937-0. doi: 10.1016/j.jaci.2018.06.027. [Epub ahead of print]

PMID:
30010542
3.

Proteomics in Chronic Arthritis-Will We Finally Have Useful Biomarkers?

Kessel C, McArdle A, Verweyen E, Weinhage T, Wittkowski H, Pennington SR, Foell D.

Curr Rheumatol Rep. 2018 Jul 14;20(9):53. doi: 10.1007/s11926-018-0762-0. Review.

PMID:
30008153
4.

Inherited p40phox deficiency differs from classic chronic granulomatous disease.

van de Geer A, Nieto-Patlán A, Kuhns DB, Tool AT, Arias AA, Bouaziz M, de Boer M, Franco JL, Gazendam RP, van Hamme JL, van Houdt M, van Leeuwen K, Verkuijlen PJ, van den Berg TK, Alzate JF, Arango-Franco CA, Batura V, Bernasconi AR, Boardman B, Booth C, Burns SO, Cabarcas F, Cerf Bensussan N, Charbit-Henrion F, Corveleyn A, Deswarte C, Esnaola Azcoiti M, Foell D, Gallin JI, Garcés C, Guedes M, Hinze CH, Holland SM, Hughes SM, Ibañez P, Malech HL, Meyts I, Moncada-Velez M, Moriya K, Neves E, Oleastro M, Perez L, Rattina V, Oleaga-Quintas C, Warner N, Muise AM, Serafin López J, Trindade E, Vasconselos J, Vermeire S, Wittkowski H, Worth A, Abel L, Dinauer MC, Arkwright PD, Roos D, Casanova JL, Kuijpers TW, Bustamante J.

J Clin Invest. 2018 Jul 3. pii: 97116. doi: 10.1172/JCI97116. [Epub ahead of print]

5.

Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria.

Hinze CH, Oommen PT, Dressler F, Urban A, Weller-Heinemann F, Speth F, Lainka E, Brunner J, Fesq H, Foell D, Müller-Felber W, Neudorf U, Rietschel C, Schwarz T, Schara U, Haas JP.

Pediatr Rheumatol Online J. 2018 Jun 25;16(1):40. doi: 10.1186/s12969-018-0257-6.

6.

The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON).

Listing M, Mönkemöller K, Liedmann I, Niewerth M, Sengler C, Listing J, Foell D, Heiligenhaus A, Klein A, Horneff G, Ganser G, Haas JP, Klotsche J, Minden K.

Arthritis Res Ther. 2018 May 30;20(1):106. doi: 10.1186/s13075-018-1588-x.

7.

Increased Circulating Proinflammatory T Lymphocytes in Children with Different Forms of Anterior Uveitis: Results from a Pilot Study.

Walscheid K, Neekamp L, Heiligenhaus A, Weinhage T, Heinz C, Foell D.

Ocul Immunol Inflamm. 2018 May 17:1-10. doi: 10.1080/09273948.2018.1467464. [Epub ahead of print]

PMID:
29771573
8.

Risk factors and biomarkers for the occurrence of uveitis in JIA: Data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study.

Tappeiner C, Klotsche J, Sengler C, Niewerth M, Liedmann I, Walscheid K, Lavric M, Foell D, Minden K, Heiligenhaus A.

Arthritis Rheumatol. 2018 May 6. doi: 10.1002/art.40544. [Epub ahead of print]

PMID:
29732713
9.

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.

Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, Schalm S, Murias S, Dare JA, Brown D, Stone DL, Gao L, Klausmeier T, Foell D, de Jesus AA, Chapelle DC, Kim H, Dill S, Colbert RA, Failla L, Kost B, O'Brien M, Reynolds JC, Folio LR, Calvo KR, Paul SM, Weir N, Brofferio A, Soldatos A, Biancotto A, Cowen EW, Digiovanna JJ, Gadina M, Lipton AJ, Hadigan C, Holland SM, Fontana J, Alawad AS, Brown RJ, Rother KI, Heller T, Brooks KM, Kumar P, Brooks SR, Waldman M, Singh HK, Nickeleit V, Silk M, Prakash A, Janes JM, Ozen S, Wakim PG, Brogan PA, Macias WL, Goldbach-Mansky R.

J Clin Invest. 2018 Jun 11. pii: 98814. doi: 10.1172/JCI98814. [Epub ahead of print]

10.

Treating juvenile idiopathic arthritis to target: recommendations of an international task force.

Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, Akikusa JD, Al-Mayouf SM, Antón J, Avcin T, Berard RA, Beresford MW, Burgos-Vargas R, Cimaz R, De Benedetti F, Demirkaya E, Foell D, Itoh Y, Lahdenne P, Morgan EM, Quartier P, Ruperto N, Russo R, Saad-Magalhães C, Sawhney S, Scott C, Shenoi S, Swart JF, Uziel Y, Vastert SJ, Smolen JS.

Ann Rheum Dis. 2018 Jun;77(6):819-828. doi: 10.1136/annrheumdis-2018-213030. Epub 2018 Apr 11.

PMID:
29643108
11.

The German version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Holzinger D, Foell D, Horneff G, Foeldvari I, Tzaribachev N, Tzaribachev C, Minden K, Kallinich T, Ganser G, Clara L, Haas JP, Hügle B, Huppertz HI, Weller F, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):211-218. doi: 10.1007/s00296-018-3953-0. Epub 2018 Apr 7.

12.

IL-6 blockade in systemic juvenile idiopathic arthritis - achievement of inactive disease and remission (data from the German AID-registry).

Bielak M, Husmann E, Weyandt N, Haas JP, Hügle B, Horneff G, Neudorf U, Lutz T, Lilienthal E, Kallinich T, Tenbrock K, Berendes R, Niehues T, Wittkowski H, Weißbarth-Riedel E, Heubner G, Oommen P, Klotsche J, Foell D, Lainka E.

Pediatr Rheumatol Online J. 2018 Apr 5;16(1):22. doi: 10.1186/s12969-018-0236-y.

13.

Anti-inflammatory monocytes-interplay of innate and adaptive immunity.

Varga G, Foell D.

Mol Cell Pediatr. 2018 Apr 3;5(1):5. doi: 10.1186/s40348-018-0083-4. Review.

14.

IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis.

Arthur VL, Shuldiner E, Remmers EF, Hinks A, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Oliveira S, Yeung RSM, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rösen-Wolff A, Minden K, Szymanski AM; INCHARGE Consortium, Thomson W, Kastner DL, Woo P, Ombrello MJ.

Arthritis Rheumatol. 2018 Apr 2. doi: 10.1002/art.40498. [Epub ahead of print]

PMID:
29609200
15.

Identification of an Amino Acid Motif in HLA-DRβ1 That Distinguishes Uveitis in Patients With Juvenile Idiopathic Arthritis.

Haasnoot AJW, Schilham MW, Kamphuis S, Hissink Muller PCE, Heiligenhaus A, Foell D, Minden K, Ophoff RA, Radstake TRDJ, Den Hollander AI, Reinards THCM, Hiddingh S, Schalij-Delfos NE, Hoppenreijs EPAH, van Rossum MAJ, Wouters C, Saurenmann RK, van den Berg JM, Wulffraat NM; ICON-JIA Study Group, Ten Cate R, de Boer JH, Pulit SL, Kuiper JJW.

Arthritis Rheumatol. 2018 Jul;70(7):1155-1165. doi: 10.1002/art.40484. Epub 2018 May 29.

PMID:
29513936
16.

Serum S100 Proteins as a Marker of Disease Activity in Large Vessel Vasculitis.

Springer JM, Monach P, Cuthbertson D, Carette S, Khalidi NA, McAlear CA, Pagnoux C, Seo P, Warrington KJ, Ytterberg SR, Hoffman G, Langford C, Hamilton T, Foell D, Vogl T, Holzinger D, Merkel PA, Roth J, Hajj-Ali RA.

J Clin Rheumatol. 2018 Feb 22. doi: 10.1097/RHU.0000000000000729. [Epub ahead of print] No abstract available.

PMID:
29470262
17.

Reversal of Sepsis-Like Features of Neutrophils by Interleukin-1 Blockade in Patients With Systemic-Onset Juvenile Idiopathic Arthritis.

Ter Haar NM, Tak T, Mokry M, Scholman RC, Meerding JM, de Jager W, Verwoerd A, Foell D, Vogl T, Roth J, Leliefeld PHC, van Loosdregt J, Koenderman L, Vastert SJ, de Roock S.

Arthritis Rheumatol. 2018 Jun;70(6):943-956. doi: 10.1002/art.40442. Epub 2018 May 7.

PMID:
29426067
18.

Characterization of drug-neutralizing antibodies in patients with Fabry disease during infusion.

Lenders M, Schmitz B, Brand SM, Foell D, Brand E.

J Allergy Clin Immunol. 2018 Jun;141(6):2289-2292.e7. doi: 10.1016/j.jaci.2017.12.1001. Epub 2018 Feb 5. No abstract available.

PMID:
29421273
19.

Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.

Hinze CH, Holzinger D, Lainka E, Haas JP, Speth F, Kallinich T, Rieber N, Hufnagel M, Jansson AF, Hedrich C, Winowski H, Berger T, Foeldvari I, Ganser G, Hospach A, Huppertz HI, Mönkemöller K, Neudorf U, Weißbarth-Riedel E, Wittkowski H, Horneff G, Foell D; PRO-KIND SJIA project collaborators.

Pediatr Rheumatol Online J. 2018 Jan 22;16(1):7. doi: 10.1186/s12969-018-0224-2.

20.

S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis.

Gohar F, Anink J, Moncrieffe H, Van Suijlekom-Smit LWA, Prince FHM, van Rossum MAJ, Dolman KM, Hoppenreijs EPAH, Ten Cate R, Ursu S, Wedderburn LR, Horneff G, Frosch M, Foell D, Holzinger D.

J Rheumatol. 2018 Apr;45(4):547-554. doi: 10.3899/jrheum.170438. Epub 2018 Jan 15.

PMID:
29335345
21.

Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome.

Weiss ES, Girard-Guyonvarc'h C, Holzinger D, de Jesus AA, Tariq Z, Picarsic J, Schiffrin EJ, Foell D, Grom AA, Ammann S, Ehl S, Hoshino T, Goldbach-Mansky R, Gabay C, Canna SW.

Blood. 2018 Mar 29;131(13):1442-1455. doi: 10.1182/blood-2017-12-820852. Epub 2018 Jan 11.

PMID:
29326099
22.

Effect of Adalimumab on Peripheral Blood Mononuclear Cells in Non-Infectious Uveitis.

Walscheid K, Weinhage T, Foell D, Heinz C, Kasper M, Heiligenhaus A.

Ocul Immunol Inflamm. 2017 Oct 11:1-8. doi: 10.1080/09273948.2017.1374415. [Epub ahead of print]

PMID:
29020495
23.

Peripheral blood monocytes reveal an activated phenotype in pediatric uveitis.

Walscheid K, Neekamp L, Heiligenhaus A, Weinhage T, Holzinger D, Heinz C, Kasper M, Foell D.

Clin Immunol. 2018 May;190:84-88. doi: 10.1016/j.clim.2017.09.014. Epub 2017 Sep 18.

PMID:
28923439
24.

Effect of Continuous Motion Parameter Feedback on Laparoscopic Simulation Training: A Prospective Randomized Controlled Trial on Skill Acquisition and Retention.

Buescher JF, Mehdorn AS, Neumann PA, Becker F, Eichelmann AK, Pankratius U, Bahde R, Foell D, Senninger N, Rijcken E.

J Surg Educ. 2018 Mar - Apr;75(2):516-526. doi: 10.1016/j.jsurg.2017.08.015. Epub 2017 Aug 31.

PMID:
28864265
25.

Familial Mediterranean fever in children and adolescents: factors for colchicine dosage and predicting parameters for dose increase.

Knieper AM, Klotsche J, Lainka E, Berger T, Dressler F, Jansson AF, Rietschel C, Oommen PT, Berendes R, Niehues T, Neudorf U, Foell D, Wittkowski H, Kallinich T.

Rheumatology (Oxford). 2017 Sep 1;56(9):1597-1606. doi: 10.1093/rheumatology/kex222.

PMID:
28859329
26.

A practical guide for small bowel transplantation in rats-review of techniques and models.

Foell D, Becker F, Hadrian R, Palmes D, Kebschull L.

J Surg Res. 2017 Jun 1;213:115-130. doi: 10.1016/j.jss.2017.02.026. Epub 2017 Mar 16. Review.

PMID:
28601304
27.

The Non Operative Treatment for Acute Appendicitis (NOTA) Study: Is Less Surgery Better Surgery?

Foell D, Bahde R, Senninger N.

Ann Surg. 2017 Jun;265(6):E83-E84. doi: 10.1097/SLA.0000000000001323. No abstract available.

PMID:
28486302
28.

Phase-contrast magnet resonance imaging reveals regional, transmural, and base-to-apex dispersion of mechanical dysfunction in patients with long QT syndrome.

Brado J, Dechant MJ, Menza M, Komancsek A, Lang CN, Bugger H, Foell D, Jung BA, Stiller B, Bode C, Odening KE.

Heart Rhythm. 2017 Sep;14(9):1388-1397. doi: 10.1016/j.hrthm.2017.04.045. Epub 2017 May 4.

PMID:
28479515
29.

Munchausen by proxy syndrome mimicking systemic autoinflammatory disease: case report and review of the literature.

Wittkowski H, Hinze C, Häfner-Harms S, Oji V, Masjosthusmann K, Monninger M, Grenzebach U, Foell D.

Pediatr Rheumatol Online J. 2017 Apr 5;15(1):19. doi: 10.1186/s12969-017-0152-6. Review.

30.

Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Morishita KA, Moorthy LN, Lubieniecka JM, Twilt M, Yeung RSM, Toth MB, Shenoi S, Ristic G, Nielsen SM, Luqmani RA, Li SC, Lee T, Lawson EF, Kostik MM, Klein-Gitelman M, Huber AM, Hersh AO, Foell D, Elder ME, Eberhard BA, Dancey P, Charuvanij S, Benseler SM, Cabral DA; ARChiVe Investigators Network within the PedVas Initiative.

Arthritis Rheumatol. 2017 Jul;69(7):1470-1479. doi: 10.1002/art.40112. Epub 2017 Jun 9.

31.

Successful management of passenger lymphocyte syndrome in an ABO-compatible, nonidentical isolated bowel transplant: a case report and review of the literature.

Foell D, Glasmeyer S, Senninger N, Wolters H, Palmes D, Bahde R.

Transfusion. 2017 Jun;57(6):1396-1400. doi: 10.1111/trf.14086. Epub 2017 Mar 28. Review.

PMID:
28369932
32.

Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by γ/δ T Cells in Systemic Juvenile Idiopathic Arthritis.

Kessel C, Lippitz K, Weinhage T, Hinze C, Wittkowski H, Holzinger D, Fall N, Grom AA, Gruen N, Foell D.

Arthritis Rheumatol. 2017 Jul;69(7):1480-1494. doi: 10.1002/art.40099. Epub 2017 Jun 12.

33.

Canakinumab for first line steroid-free treatment in a child with systemic-onset juvenile idiopathic arthritis.

Horneff G, Peitz J, Kekow J, Foell D.

Scand J Rheumatol. 2017 Nov;46(6):500-501. doi: 10.1080/03009742.2017.1288827. Epub 2017 Mar 7. No abstract available.

PMID:
28266235
34.

Phenotypic changes of peripheral blood mononuclear cells upon corticosteroid treatment in idiopathic intermediate uveitis.

Walscheid K, Weinhage T, Foell D, Heinz C, Kasper M, Heiligenhaus A.

Clin Immunol. 2016 Oct 28. pii: S1521-6616(16)30534-4. doi: 10.1016/j.clim.2016.10.013. [Epub ahead of print]

PMID:
27989897
35.

Autoinflammatory diseases: New diagnostic criteria for CAPS - turning horses into zebras?

Hinze C, Foell D.

Nat Rev Rheumatol. 2017 Jan;13(1):7-8. doi: 10.1038/nrrheum.2016.201. Epub 2016 Dec 8. No abstract available.

PMID:
27928157
36.

Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications.

Ombrello MJ, Arthur VL, Remmers EF, Hinks A, Tachmazidou I, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rosen-Wolff A, Minden K, Tenbrock K, Demirkaya E, Cobb J, Baskin E, Signa S, Shuldiner E, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A; British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis (ICON-JIA) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group, Langefeld CD, Thompson S, Zeggini E, Kastner DL, Woo P, Thomson W.

Ann Rheum Dis. 2017 May;76(5):906-913. doi: 10.1136/annrheumdis-2016-210324. Epub 2016 Dec 7.

37.

S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis.

Geven EJ, van den Bosch MH, Di Ceglie I, Ascone G, Abdollahi-Roodsaz S, Sloetjes AW, Hermann S, Schäfers M, van de Loo FA, van der Kraan PM, Koenders MI, Foell D, Roth J, Vogl T, van Lent PL.

Arthritis Res Ther. 2016 Oct 24;18(1):247.

38.

Alarmins firing arthritis: Helpful diagnostic tools and promising therapeutic targets.

Lavric M, Miranda-García MA, Holzinger D, Foell D, Wittkowski H.

Joint Bone Spine. 2017 Jul;84(4):401-410. doi: 10.1016/j.jbspin.2016.06.010. Epub 2016 Sep 19.

PMID:
27659403
39.

Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?

Gohar F, Kessel C, Lavric M, Holzinger D, Foell D.

Arthritis Res Ther. 2016 Jul 13;18:163. doi: 10.1186/s13075-016-1069-z. Review.

40.

Correlation of Secretory Activity of Neutrophils With Genotype in Patients With Familial Mediterranean Fever.

Gohar F, Orak B, Kallinich T, Jeske M, Lieber M, von Bernuth H, Giese A, Weissbarth-Riedel E, Haas JP, Dressler F, Holzinger D, Lohse P, Neudorf U, Lainka E, Hinze C, Masjosthusmann K, Kessel C, Weinhage T, Foell D, Wittkowski H.

Arthritis Rheumatol. 2016 Dec;68(12):3010-3022. doi: 10.1002/art.39784.

41.

Activation-dependent cell death of human monocytes is a novel mechanism of fine-tuning inflammation and autoimmunity.

Däbritz J, Weinhage T, Varga G, Wirth T, Ehrchen JM, Barczyk-Kahlert K, Roth J, Schwarz T, Foell D.

Eur J Immunol. 2016 Aug;46(8):1997-2007. doi: 10.1002/eji.201545802. Epub 2016 May 27.

42.

[Translational research in pediatric rheumatology. Current research approaches to the innate immune system].

Lippitz K, Waldkirch J, Kessel C, Varga G, Foell D.

Z Rheumatol. 2016 Apr;75(3):276-83. doi: 10.1007/s00393-015-0040-8. Review. German.

PMID:
26800663
43.

Electro-mechanical dysfunction in long QT syndrome: Role for arrhythmogenic risk prediction and modulation by sex and sex hormones.

Lang CN, Menza M, Jochem S, Franke G, Perez Feliz S, Brunner M, Koren G, Zehender M, Bugger H, Jung BA, Foell D, Bode C, Odening KE.

Prog Biophys Mol Biol. 2016 Jan;120(1-3):255-69. doi: 10.1016/j.pbiomolbio.2015.12.010. Epub 2015 Dec 21.

PMID:
26718598
44.

Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis.

Cypers H, Varkas G, Beeckman S, Debusschere K, Vogl T, Roth J, Drennan MB, Lavric M, Foell D, Cuvelier CA, De Vos M, Delanghe J, Van den Bosch F, Elewaut D.

Ann Rheum Dis. 2016 Jul;75(7):1357-62. doi: 10.1136/annrheumdis-2015-208025. Epub 2015 Dec 23.

45.

Myocardial dysfunction in patients with aortic stenosis and hypertensive heart disease assessed by MR tissue phase mapping.

von Knobelsdorff-Brenkenhoff F, Hennig P, Menza M, Dieringer MA, Foell D, Jung B, Schulz-Menger J.

J Magn Reson Imaging. 2016 Jul;44(1):168-77. doi: 10.1002/jmri.25125. Epub 2015 Dec 21.

PMID:
26687082
46.

No association of IL-12p40 pro1.1 polymorphism with juvenile idiopathic arthritis.

Eberhardt CS, Haas JP, Girschick H, Schwarz T, Morbach H, Rösen-Wolff A, Foell D, Dannecker G, Schepp C, Ganser G, Honke N, Eggermann T, Müller-Berghaus J, Wagner N, Ohl K, Tenbrock K.

Pediatr Rheumatol Online J. 2015 Dec 15;13:61. doi: 10.1186/s12969-015-0059-z.

47.

Elevated S100A8/A9 and S100A12 Serum Levels Reflect Intraocular Inflammation in Juvenile Idiopathic Arthritis-Associated Uveitis: Results From a Pilot Study.

Walscheid K, Heiligenhaus A, Holzinger D, Roth J, Heinz C, Tappeiner C, Kasper M, Foell D.

Invest Ophthalmol Vis Sci. 2015 Dec;56(13):7653-60. doi: 10.1167/iovs.15-17066.

PMID:
26624497
48.

HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis.

Ombrello MJ, Remmers EF, Tachmazidou I, Grom A, Foell D, Haas JP, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Mellins ED, Ilowite NT, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg A, Wedderburn LR, Anton J, Schwarz T, Hinks A, Bilginer Y, Park J, Cobb J, Satorius CL, Han B, Baskin E, Signa S, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A; British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group; Childhood Arthritis Prospective Study (CAPS) Group; Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators; Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group; Biologically Based Outcome Predictors in JIA (BBOP) Group, de Bakker PI, Raychaudhuri S, Langefeld CD, Thompson S, Zeggini E, Thomson W, Kastner DL, Woo P; International Childhood Arthritis Genetics (INCHARGE) Consortium.

Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15970-5. doi: 10.1073/pnas.1520779112. Epub 2015 Nov 23.

49.

Sleep Fragmentation and Biomarkers in Juvenile Idiopathic Arthritis.

Ward TM, Yuwen W, Voss J, Foell D, Gohar F, Ringold S.

Biol Res Nurs. 2016 May;18(3):299-306. doi: 10.1177/1099800415609997. Epub 2015 Oct 27.

50.

Increased serum concentrations of neutrophil-derived protein S100A12 in heterozygous carriers of MEFV mutations.

Lieber M, Kallinich T, Lohse P, Klotsche J, Holzinger D, Foell D, Wittkowski H.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S113-6. Epub 2015 Oct 19.

PMID:
26486615

Supplemental Content

Support Center